Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Brain Res ; 1038(2): 141-9, 2005 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-15757630

RESUMEN

Glia represents the most numerous group of nervous system cells and CNS development and function depend on glial cells. We developed a purified Muller glia culture to investigate the expression of several neurotransmitter markers on these cells, such as dopaminergic, cholinergic, GABAergic and peptidergic receptors or enzymes, based on functional assays measuring second messenger levels or Western blot for specific proteins. Purified Muller cell culture was obtained from 8-day-old (E8) embryonic chick. Glial cells cultured for 15 days (E8C15) expressed D1A and D1B receptors mRNAs, but not D1D, as detected by RT-PCR. The binding of [3H]-SCH 23390 revealed an amount of expressed receptors around 40 fmol/mg protein. Dopamine (100 microM), PACAP (50 nM) and forskolin (10 microM) induced a 50-, 30- and 40-fold cAMP accumulation on glial cells, respectively, but not ip3 production. The dopamine-promoted cAMP accumulation was blocked by 2 microM SCH 23390. Carbachol stimulated a 3-fold ip3 accumulation. Western blot analysis also revealed the expression of tyrosine hydroxylase, L-dopa decarboxylase, PAC1 receptor, GAD67 and beta2-nicotinic receptor subunit by these cells. These results indicate that several components of neurotransmitter signaling and metabolism are found in cultured Muller cells.


Asunto(s)
Neuroglía/metabolismo , Neurotransmisores/metabolismo , Receptores de Neurotransmisores/metabolismo , Animales , Benzazepinas/metabolismo , Biomarcadores , Western Blotting , Células Cultivadas , Embrión de Pollo , Colforsina/farmacología , AMP Cíclico/metabolismo , Dopamina/metabolismo , Dopamina/farmacología , Antagonistas de Dopamina/metabolismo , Inositol 1,4,5-Trifosfato/metabolismo , Factores de Crecimiento Nervioso/farmacología , Neuroglía/enzimología , Neuronas/metabolismo , Neuropéptidos/farmacología , Neurotransmisores/farmacología , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa , Racloprida/metabolismo , Receptores de Dopamina D1/genética , Receptores de Dopamina D1/metabolismo , Retina/citología , Retina/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
2.
J Neurosci Res ; 59(2): 202-8, 2000 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-10650878

RESUMEN

The D4 receptor (D4R), a member of the dopamine D2-like receptor family, has been implicated in the pathophysiology of several diseases and has been the target of various investigations regarding its distribution and quantification. The brain distribution of the D4R has been well described in various species, but the quantification is still an issue of controversy, because no specific ligand is commercially available. To circumvent this difficulty we have performed a biochemical and autoradiographical study in brain samples obtained from mice lacking D4Rs and their wild-type siblings; comparison of their binding parameters allows a more accurate quantification of the members of the D2-like receptor family (D2, D3, and D4 receptors). We found that the distribution of D2-like receptors in mouse brain is similar to that of rat brain, i.e., caudate putamen, nucleus accumbens, olfactory tubercle, and hippocampus. The contribution of the D4R to the overall population of D2-like receptors is 17% in nucleus accumbens, 21% in caudate putamen and olfactory tubercle, and 40% in hippocampus. Based on our study we conclude that nemonapride probably binds to nondopaminergic sites that if not properly blocked may lead to overestimations of D4R levels. We observed that the experimental condition that better estimates the density of D4 receptors is the displacement of D2 and D3 [3H]nemonapride binding sites with cold raclopride.


Asunto(s)
Química Encefálica/genética , Carácter Cuantitativo Heredable , Receptores de Dopamina D2/genética , Animales , Autorradiografía , Benzamidas/metabolismo , Benzamidas/farmacología , Sitios de Unión , Antagonistas de Dopamina/metabolismo , Antagonistas de Dopamina/farmacología , Femenino , Ligandos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Racloprida/metabolismo , Racloprida/farmacología , Ensayo de Unión Radioligante , Receptores de Dopamina D2/química , Receptores de Dopamina D2/metabolismo , Receptores de Dopamina D4 , Sinaptosomas/química , Sinaptosomas/metabolismo , Tritio
3.
Psychopharmacology (Berl) ; 146(3): 262-7, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10541725

RESUMEN

RATIONALE: Stimulation of locomotor activity by low doses of ethanol (EtOH) and the potentiation of this response after repeated administration (sensitization) have been related to EtOH's rewarding and addictive properties and to altered dopaminergic activity in brain. In mice, behavioral sensitization to EtOH occurs only in a subset of treated animals, and this provides an opportunity for distinguishing general drug effects from sensitization-specific brain effects. OBJECTIVES: In view of evidence suggesting a role for dopamine D2 receptors in EtOH preference and abuse liability, the present study addressed the hypothesis that D2 binding would be altered in specific brain regions in mice showing differential sensitization responses to chronic EtOH administration. METHODS: Male albino Swiss mice received 2.4 g/kg EtOH i.p. daily for 21 days and were then separated into sensitized or non-sensitized subgroups on the basis of weekly locomotor activity tests. RESULTS: Autoradiographic analyses of [(3)H]raclopride binding to D2 sites revealed significant increases in the anterior caudate-putamen of mice in the EtOH-sensitized group when compared with either saline controls (+40%, P<0.00009) or to mice in the EtOH non-sensitized group (+32%; P<0.0003). Smaller increases were seen in the ventrolateral caudate-putamen of sensitized animals (+18% vs. control, P<0.02; and 12% vs. non-sensitized mice, P<0.07). No differences were found in other brain regions, including the nucleus accumbens, olfactory bulb and substantia nigra. CONCLUSIONS: The observed increases in D2-receptor binding in circumscribed targets of nigrostriatal projections may reflect either a pre-existing condition in sensitization-prone animals or a selective vulnerability of D2 receptors to chronic EtOH in these animals. In either case, it may be a marker for differential susceptibility to EtOH sensitization.


Asunto(s)
Encéfalo/efectos de los fármacos , Etanol/farmacología , Receptores de Dopamina D2/efectos de los fármacos , Animales , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Racloprida/metabolismo , Receptores de Dopamina D2/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA